title: Expanded carrier screening and the law of unintended consequences: from cystic fibrosis to fragile X.
authors: Divisions of Medical Genetics and Molecular Pathology, Departments of Pathology & Laboratory Medicine, Pediatrics, and Human Genetics, UCLA School of Medicine, Los Angeles, California, USA. wgrody@mednet.ucla.edu
authors: Wayne W
authors: WW
authors: Grody
mesh_terms: D003550:Cystic Fibrosis / Q000175:diagnosis* / Q000235:genetics; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics; D051860:Fragile X Messenger Ribonucleoprotein 1 / Q000235:genetics; D005600:Fragile X Syndrome / Q000175:diagnosis* / Q000235:genetics; D005820:Genetic Testing; D005826:Genetics, Medical / Q000941:ethics* / Q000592:standards; D005828:Genetics, Population / Q000941:ethics* / Q000592:standards; D006579:Heterozygote; D006801:Humans; D009154:Mutation
chemical_list: D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D051860:Fragile X Messenger Ribonucleoprotein 1; C505032:CFTR protein, human; C497683:FMR1 protein, human